Confirmatory study of the effect of ingestion of food containing seaweed extract on the intestinal environment - Confirmatory study of the effect of ingestion of food containing seaweed extract on the intestinal environment

HUMA R&D CORP0 sites32 target enrollmentJanuary 8, 2021

ConditionsHealthy subjects

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy subjects
Sponsor: HUMA R&D CORP
Enrollment: 32
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 8, 2021

End Date

April 21, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

HUMA R&D CORP

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\.Subject with a history of comorbidities in the digestive organs (excluding a history of cecum) 2\.Subject who is taking medication or under medical treatment 3\.Subject who is under exercise therapy or dietetic therapy 4\.Subject who may develop allergies due to the test foods and who may cause serious allergic symptoms to other foods and medicines 5\.Subject with current or history of drug dependence or alcohol dependence 6\.Heavy drinkers 7\.Subject who is out of the hospital due to mental disorders (depression, etc.) or sleep disorders, or who have a history of mental illness in the past 8\.Subject with irregular life rhythms due to night shifts or shift work 9\.Subject with extremely irregular lifestyle habits such as eating and sleeping 10\.Subject who has an extremely unbalanced diet 11\.Subject who has difficulty in taking the full amount of the prescribed diet 12\.Serious diseases such as brain disease, malignant tumor, immune disease, diabetes, liver disease (hepatitis), renal disease, heart disease, thyroid disease, adrenal disease, and other serious current or past diseases such as metabolic disease those who have 13\.Subject who uses health foods, supplements, and medicines that have an intestinal regulating effect 14\.Subject who has participated in other clinical trials (research) within 3 months from the date of consent acquisition or who plan to participate in other clinical trials (research) during the trial period 15\.Subject who has collected 200 mL of blood or donated more than 400 mL of blood within 3 months from the date of consent acquisition 16\.Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating 17\.Subject who has a smoking habit 18\.Subject who has difficulty observing records on various survey forms 19\.Subject who is judged as an inappropriate candidate according to the screening data 20\.Subject who is considered as an inappropriate candidate by the doctor in charge